UDI Implementation Guide for Korea and Global Markets

What Korean UDI Is, and Is Not

Korea's UDI (Unique Device Identification) system has been mandatory for Class IV devices since 2019 and was phased into Class III in 2020, Class II in 2022, and Class I in 2024. The system uses GS1 Korea-issued codes integrated into the MFDS UDI database (UDI-DI registration).

A Korean UDI consists of:

1. UDI-DI (Device Identifier) — the static product identifier, encoded as a GS1 GTIN. Identifies the make and model.
2. UDI-PI (Production Identifier) — the dynamic production data: lot number, serial number, expiration date, manufacturing date. Identifies the specific instance.
3. Carrier — the physical encoding on the label, typically a GS1 DataMatrix or GS1-128 barcode.
4. UDI database registration — the UDI-DI and product metadata registered in the MFDS UDI Information Service Center.

Korean UDI is not identical to FDA UDI or EU EUDAMED UDI. Manufacturers shipping to multiple regions cannot rely on a single UDI implementation; the carriers and databases differ.

Where Korean UDI Diverges from FDA and EU

Element	FDA UDI	EU EUDAMED	Korea UDI
Issuing agency	GS1, HIBCC, ICCBBA	GS1, HIBCC, ICCBBA, IFA	GS1 Korea (preferred)
Database	GUDID	EUDAMED	MFDS UDI-DI System
Submission party	Labeler (manufacturer or specification developer)	Manufacturer	KLH (in most cases)
Carrier requirement	One carrier (DataMatrix or linear)	DataMatrix preferred	DataMatrix preferred
Reusable devices	Direct marking required on Class II+	Direct marking on reusable Class III	Direct marking on Class III/IV
Implant card	Not required	Required (Annex XIII)	Required for implantables
Effective dates	Class III: 2014; Class II: 2018; Class I: 2022	Class III: May 2021; ramping by class	Class IV: 2019; ramping to Class I: 2024

Three practical implications:

1. A single UDI carrier can serve all three markets if structured as GS1 DataMatrix containing GTIN + production data. The carriers are reusable.

2. The database registrations are not reusable. FDA GUDID, EU EUDAMED, and MFDS UDI-DI each have their own data schema. Records must be submitted to each system.

3. The submitting party differs. FDA: the labeler. EU: the manufacturer. Korea: the KLH (acting as importer for foreign manufacturers). The submission workflow has to accommodate three different filers.

What Goes into UDI-DI Registration in Korea

The MFDS UDI-DI registration captures product metadata including:

• GTIN (or HIBCC/ICCBBA identifier if not GS1)
• Product name (Korean and English)
• MFDS notification or approval number
• Manufacturer name and address
• KLH name and address
• Item code (Korean classification)
• Single-use vs reusable
• Sterile vs non-sterile
• Implantable vs non-implantable
• Latex content (yes/no/not stated)
• Storage conditions
• Compatible accessories (UDI-DI cross-references)
• Image of the product label (showing the UDI carrier in context)

For multi-SKU portfolios, the UDI-DI database becomes the canonical product master in Korea. Maintaining the database is an ongoing responsibility, not a one-time submission.

The Implementation Sequence

For a foreign manufacturer launching in Korea, UDI implementation runs in parallel with the MFDS registration:

Phase 1: GTIN Assignment

Obtain GS1 Korea company prefix (if not already a GS1 member globally). Assign GTINs to each Korean SKU. The GTIN is the same product identifier used in FDA and EU systems — manufacturers with existing global GS1 membership can reuse their GTINs.

Phase 2: Carrier Design

Design the UDI carrier on the Korean label:

• GS1 DataMatrix with structured encoding (Application Identifiers per GS1 spec)
• Human-readable text below the carrier showing the data elements
• Carrier placement that survives sterile processing (for sterile devices), reprocessing (for reusable devices), and patient implantation (for direct-marked implants)

Carrier design is often the area where existing label templates need refresh. Pre-UDI Korean labels typically have lot number and expiration in human-readable form but no machine-readable encoding.

Phase 3: Direct Marking (Where Applicable)

For reusable devices in Class III/IV, direct marking on the device itself is required. This is typically laser engraving or chemical etching, integrated into manufacturing. Direct marking adds a step to manufacturing process validation and KGMP scope.

Phase 4: UDI-DI Database Registration

The KLH submits the UDI-DI record to MFDS through the MFDS UDI Information Service Center portal. The submission is per SKU, with the metadata listed above. Approval is typically 5–10 business days.

Phase 5: Lifecycle Maintenance

Once registered, the UDI-DI record must be updated when:

• Product specifications change
• KLH changes
• Compatible accessories are added or removed
• The product is discontinued
• Material changes affect any registered field

The maintenance burden is light per SKU but adds up across portfolios.

How UDI Connects to Labeling, Vigilance, and PMS

UDI is the connective tissue between several otherwise-separate Korean regulatory regimes:

• Labeling — the UDI carrier is part of the label; labeling changes that affect the carrier require notification.
• Vigilance — adverse event reports identify the device by UDI-DI + UDI-PI, enabling MFDS to query for events related to a specific lot or serial.
• PMS — post-market surveillance analyses use UDI for cohort definition.
• Import records — the KLH import record captures UDI data per shipment, tying customs/import records to UDI.
• Recall management — recalls are scoped by UDI, enabling precise lot-level recall rather than blanket product recall.

Manufacturers running clean UDI implementation report significant operational benefits beyond pure compliance — particularly in recall scope reduction and complaint analysis speed.

Implementation Cost and Effort

For a manufacturer with 10–20 SKUs in Korea:

• GS1 membership and GTIN assignment: ~₩2M one-time + annual membership
• Label redesign and printing setup: 4–8 weeks of label work + new printing setup costs
• Direct marking equipment (for reusable devices): ₩30M–₩200M depending on technology
• Manufacturing process validation update: 4–8 weeks
• UDI-DI database registration: 1–2 weeks per SKU
• Internal procedures and training: 2–4 weeks

Total implementation: ~3–6 months for a clean portfolio without direct-marking complexity; 6–12 months when direct marking is involved.

Common Implementation Mistakes

Mistake 1: Treating UDI as just labeling. UDI is a regulatory data system that happens to have a labeling component. Implementing only the label and skipping the database registration leaves the manufacturer non-compliant.

Mistake 2: Single-region implementation. Building a Korea-only UDI program when FDA UDI and EU EUDAMED are also in scope is duplicative. A multi-region UDI strategy designed once is cheaper than three sequential single-region implementations.

Mistake 3: KLH not in the implementation loop. The KLH is the submitter for Korean UDI-DI records. Manufacturers implementing UDI without involving the KLH end up with incomplete submissions or submissions made under the wrong party.

Mistake 4: Ignoring compatibility relationships. UDI-DI records require cross-references to compatible accessories. Building these out for the first SKU is straightforward; retrofitting them across an existing portfolio is significant work.

Where Leanabl Plugs In

UDI implementation runs through the Labeling service, which handles carrier design, label redesign, GS1 setup, and database registration coordination. For multi-region UDI strategy and the integration across FDA/EU/Korea, Regulatory Foundations sets the architecture. Korean UDI database maintenance specifically integrates with Korea License Maintenance.